BERG CEO Niven R. Narain explains to Fox Business News how BERG will help business partner Sanofi to improve its flu vaccines. Read the Fox Business News article: http://www.foxbusiness.com/features/2018/01/15/flu-pocalypse-why-scientists-are-scrambling-to-make-universal-influenza-vaccine.html

BERG CEO Niven R. Narain talks with WBZ Radio’s Jeff Brown about how BERG, Mass General Hospital and Brigham and Women’s Hospital will work together to battle Alzheimer’s Disease. Listen to the interview.

In a Nov. 20 Forbes.com column that highlights two high-profile Parkinson’s Disease patients — Rev. Jesse Jackson and Michael J. Fox — Capitol Hill policy advisor Nicole Fisher writes about how BERG’s partnership with AstraZeneca may have a positive impact on treating this debilitating disease. To learn more about the BERG-AstraZeneca partnership, read the entire…

A new translational research fellowship has been established to continue the pioneering work of retired Army Col. (Dr.) David G. McLeod, who devoted nearly 50 years to prostate cancer research and treatment as a military urologist. He retired in 2016 as founding director of the Center for Prostate Disease Research (CPDR) at the Uniformed Services…

BERG President and CEO Niven Narain tells BBC Radio’s World Business Report about how a partnership with the French pharmaceuticals company, Sanofi, could bring about a better flu vaccine. Learn more. The BERG-Sanofi partnership segment begins at the 17:36 mark of the program.

Biopharma and med-tech firm BERG is teaming up with Sanofi Pasteur (the vaccines division of French drug giant Sanofi) to launch a new research effort that uses AI to try and improve flu vaccine outcomes. Learn more.